PF-Atlas › Clinical Trials › NCT02003911

Azithromycin for Children Hospitalized With Asthma

Azithromycin · Phase 4

Registry ID
NCT02003911
Phase
Phase 4
Status
Terminated
Drug / intervention
Azithromycin
Sponsor
Montefiore Medical Center
Start
2013-10
Enrollment
159
Locations
1

About this trial

Asthma is a chronic lung condition in children, and often requires hospitalization for acute exacerbations. Azithromycin has been used successfully in other chronic lung diseases, including cystic fibrosis. Despite limited clinical evidence, some pediatricians use azithromycin in children hospitalized with asthma, citing either treatment of atypical pathogens or its proposed anti-inflammatory properties. This study proposes a clinical trial to determine if azithromycin will shorten length of stay in children hospitalized with acute asthma exacerbations.

View NCT02003911 on ClinicalTrials.gov →

Explore related

All Azithromycin trialsAll IPF trials

Related trials

azithromycin — NCT02173145Azithromycin — NCT01270074Azithromycin — NCT05842681Azithromycin — NCT02960503Azithromycin — NCT02803944
Medical disclaimer. This page summarizes public trial data for NCT02003911 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.